ACMS Members
  • Find a Surgeon
  • ASMH
  • Member Login
  • ×

Emily S. Ruiz, MD, MPH, FACMS

Present Affiliation

  • Brigham and Women’s Hospital, Dana-Farber Cancer Institute
  • Assistant Professor of Dermatology, Harvard Medical School

Medical School

  • New York University School of Medicine (MD), 2010
  • Harvard Chan School of Public Health (MPH), 2016

Residency and Fellowship Training

  • Residency: Albert Einstein College of Medicine (Dermatology Residency), 2014
  • Fellowship: Brigham and Women’s Hospital (Micrographic Surgery and Dermatologic Oncology Fellowship), 2016

Professional Activities

  • Program Director, Micrographic Surgery and Dermatologic Oncology Fellowship, BWH, 2022-present
  • Director, High-risk skin cancer clinic, DFCI, 2016-present
  • Academic Director, Mohs Dermatologic Surgery Center, BWH, 2020-present
  • Associate PD, Micrographic Surgery and Dermatologic Oncology Fellowship, BWH, 2019-2022
  • Quality Improvement Committee, BWH, 2017-P

American College of Mohs Surgery activities:

  • National Registry & Outcomes, Performance Measure Subcommittee 2016-2018
  • National Registry & Outcomes, Data Use and Validation Subcommittee, 2020-present
  • National Registry & Outcomes Mohs-Epic AIQ Subcommittee, 2020-present
  • Board Certification Taskforce, 2018-2021
  • Tromovitch Award Committee, 2018-2022

Other national, state and local dermatology society activities:

  • International Immunosuppression & Transplant Dermatology Collaborative, Board of Directors, 2019-2022
  • International Society for Dermatologic Surgery, Chair, 2022-present
  • Harvard Combined Dermatology Residency, Dermatology Surgery Curriculum Committee, 2018-present
  • NCI Clinical Trial Network, Executive Planning Committee for Clinical Trials Planning Meeting on High-Risk/Advanced CSCC, 2022-2023

Medical Society, Government and/or Professional Appointments, Awards and Honors:

  • JAAD Game Changer, Top 10 Most influential publication in 2022, JAAD, 2022       
  • Tromovitch Award Finalist, 2015, 2016
  • Statemen’s Scholarship, ISDS, 2014
  • Chief Resident, Division of Dermatology, Albert Einstein College of Medicine, 2013-2014
  • Maurice Freiman Memorial Award, NYU School of Medicine, 2006

Publications:

  • Author of 73 publications

Position Statement:

As an active member of the American College of Mohs Surgery, I understand the central role our organization plays in our careers as Mohs surgeons. I have had the pleasure of serving on ACMS committees and participating in annual meetings. I welcome the opportunity to serve as a board member of the ACMS and have a direct impact on our Mohs community. While there are a number of important issues within our field that I would be delighted to support, I have a particular interest in the following areas.

I am dedicated to furthering the scientific mission of the ACMS. Publishing quality data is central to our specialty for not only direct patient care, but also the advocacy efforts. I am particularly skilled in this area given my robust clinical research program, which includes large cohort studies, health services research, and clinical trials. Over the past few years, I have coordinated multicenter collaborations with the goal of providing larger scale data not only for SCC and BCC, but also for less common tumors routinely treated with MMS. These collaborations are in line with the ACMS High-Risk Cancer Collaboration, and I would be delighted to work with the ACMS to expand on such efforts.

I am also committed to supporting the important advocacy work of the ACMS. This is an important area that is constantly evolving. In addition to navigating CMS reimbursement guidelines, we are faced with other important issues, including bedside compounding and national shortages. As a board member, I will support advocacy efforts directed at preserving the excellent care that we provide to our patients.   

I also am committed to membership engagement, in particular increasing junior and mid-level ACMS participation, as well as continuing to increase diversity within our community. The ACMS has made great strides in increasing junior membership engagement and gender representation and has important initiatives to increase other underrepresented groups. This is an area of particular importance to me and I would work with the ACMS and other board members toward this effort.  

Finally, Mohs surgery needs to be viewed as the cornerstone of skin cancer treatment by other specialties. I have spearheaded multi-disciplinary collaborations within my own institution and would work with the ACMS to strengthen connections with other non-dermatologic organizations

As a board member, I am dedicated to supporting these areas listed above, but also any effort that needs attention.